Saturday, February 2, 2019

Novartis's Kymriah cell therapy won the blessing of health authorities in England for adult lymphoma patients, the Swiss drugmaker said on Friday, reversing last year's rejection.


from Reuters: Health News https://reut.rs/2TtqcDK

Related Posts:

  • LATEST HEALTH NEWS(Reuters Health) - Young women with unhealthy levels of fats in their blood may have higher odds of having just one child, or no children at all, a recent study suggests. from Reuters: Health News https://ift.tt/2LgVvRa … Read More
  • LATEST HEALTH NEWSA court hearing on a Texas law requiring the burial or cremation of aborted fetal tissue opened on Monday with the state arguing the requirement was a matter of dignity, while abortion providers called it unnecessary and aime… Read More
  • LATEST HEALTH NEWSA federal judge ruled on Monday against birth control organizations that sought to block the Trump administration from shifting a federal family-planning grant program toward prioritizing groups that are faith-based and couns… Read More
  • LATEST HEALTH NEWSA mass radio campaign in Burkina Faso led to a significant rise in sick children getting medical attention and could prove one of the most cost-effective ways to save young lives in poor countries, researchers said on Tuesday… Read More
  • LATEST HEALTH NEWSSilicon Valley e-cigarette start-up Juul Labs is bringing its small flash drive-sized vaping device to the United Kingdom this week, aiming to reproduce its break-neck U.S. growth overseas. from Reuters: Health News http… Read More

0 comments:

Post a Comment

Followers

Contact Form

Name

Email *

Message *

Popular Posts

FOLLOW BY EMAIL

Enter your email address:

Delivered by FeedBurner